Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

Author:

Panayidou Klea1,Davies Mary-Ann2ORCID,Anderegg Nanina1,Egger Matthias12ORCID,

Affiliation:

1. Institute of Social and Preventive Medicine; University of Bern; Bern Switzerland

2. Centre for Infectious Disease Epidemiology and Research; School of Public Health and Family Medicine; University of Cape Town; Cape Town South Africa

Funder

National Institute of Allergy and Infectious Diseases

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Cancer Institute

National Institute of Mental Health

National Institute on Drug Abuse

Department of Health and Ageing, Australian Government

National Institutes of Health

Agence Nationale de Recherches sur le Sida et les Hépatites Virales

Augustinus Fonden

Ministerie van Volksgezondheid, Welzijn en Sport

Seventh Framework Programme

National Institute of Child Health and Human Development

National Institute of Dental and Craniofacial Research

National Institute of Neurological Disorders and Stroke

National Institute on Deafness and Other Communication Disorders

Office of AIDS Research

National Institute on Alcohol Abuse and Alcoholism

Harvard T.H. Chan School of Public Health

Tulane University

Pediatric AIDS Clinical Trials Group (PACTG)

IMPAACT Group

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference46 articles.

1. WHO Antiretroviral therapy of HIV infection in infants and children: towards universal access 2006 http://www.who.int/hiv/pub/paediatric/infants/en/index.html

2. WHO Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach: 2010 revision 2010 http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html

3. WHO Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Summary of key features and recommendations 2013 http://www.who.int/hiv/pub/guidelines/arv2013/short_summary/en/index.html

4. World Health Organization Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015 http://who.int/hiv/en/

5. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis;Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee;AIDS,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3